Chart — Oncology
Breast Mass: Benign vs Malignant
The classic exam contrast: a benign lump tends to be soft, mobile, and tender, while a malignant one is more often hard, fixed, and painless with skin or nipple changes. Any new mass still needs evaluation.
Educational use only. These features only raise or lower suspicion — they do not diagnose. Any new or changing breast mass requires provider evaluation and imaging/biopsy. This chart is an educational aid. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
Side by Side
| Feature | Likely benign | Suspicious for malignancy |
|---|---|---|
| Consistency | Soft or rubbery | Hard, firm |
| Mobility | Mobile, moves freely | Fixed to skin or chest wall |
| Borders | Smooth, well-defined, round | Irregular, poorly defined |
| Tenderness | Often tender (esp. cysts, cyclic) | Usually painless |
| Skin / nipple changes | None | Dimpling, retraction, peau d'orange, nipple discharge/inversion |
| Number / laterality | Can be bilateral/multiple (fibrocystic) | Usually single, unilateral |
| Typical examples | Fibroadenoma (young), simple cyst, fibrocystic changes | Invasive ductal/lobular carcinoma |
Exam Traps
- ✦Malignant clues: hard, fixed, irregular, PAINLESS, single/unilateral, with skin dimpling or nipple retraction.
- ✦Benign clues: soft/rubbery, mobile, smooth, often tender; fibrocystic changes can be bilateral.
- ✦Fibroadenoma is the most common benign tumor in young women; simple cysts are common in fibrocystic change.
- ✦Peau d'orange with a red, warm breast = inflammatory breast cancer (not infection) — urgent.
- ✦Features only adjust suspicion — ANY new mass needs imaging (mammogram/ultrasound) ± biopsy.
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with Oncology Nursing Society (ONS) · National Comprehensive Cancer Network (NCCN) · American Society of Clinical Oncology (ASCO). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →